Analytical Method Validation Workflow

🧪

Analytical Method Validation - Proving the Method Measures What It Claims

Analytical method validation is the documented process of demonstrating that an analytical procedure is suitable for its intended purpose, whether identification, impurity control, or assay determination. ICH Q2(R2), revised in 2023 and now aligned with ICH Q14's analytical procedure development framework, defines the specific validation characteristics, such as specificity, accuracy, precision, and linearity, that must be evaluated based on the method's intended use. 21 CFR 211.165(e) requires that test methods used to determine conformance to specifications be validated, making this documented evidence a direct prerequisite for relying on the method's results at all.

ICH Q2(R2) · USP <1225> · ICH Q14 · 21 CFR 211.165(e)

ICH Q2(R2)

USP <1225>

ICH Q14

21 CFR 211.165(e)

Specificity / Selectivity

The method's ability to unequivocally assess the analyte in the presence of expected interferences, such as degradants, impurities, or matrix components.

Applies to: All method types

Accuracy and Precision

Accuracy reflects closeness to the true value; precision reflects agreement among repeated measurements, covering repeatability and intermediate precision.

Applies to: Assay, quantitative impurity

Linearity and Range

The method's ability to produce results directly proportional to analyte concentration across the range it will actually be used for.

Applies to: Assay, quantitative impurity

Detection / Quantitation Limits

The lowest analyte amount reliably detected or reliably quantitated, relevant specifically to trace-level impurity determination methods.

Applies to: Impurity limit and quantitative methods

Phase 1

Method Development and Validation Planning

1Define the Analytical Target Profile

ATP defined describing the required performance characteristics the method must achieve for its intended use, guiding both development and validation.

ICH Q14

↓

2Determine required validation characteristics

Validation characteristics required determined by method category per ICH Q2(R2), whether identification, limit test, quantitative impurity, or assay.

ICH Q2(R2)

↓

3Develop the validation protocol

Protocol developed with pre-defined, documented acceptance criteria for every characteristic to be evaluated, approved before execution begins.

ICH Q2(R2)

↓

4Qualify reference standards and critical reagents

Reference standards and any critical reagents qualified and documented before use in validation testing.

USP <1225>

Phase 2

Validation Protocol Execution

5Execute specificity testing

Specificity demonstrated against potential interferences, including relevant degradants, impurities, and matrix components expected in real samples.

ICH Q2(R2)

↓

6Execute accuracy and precision studies

Accuracy assessed through recovery studies, and precision assessed through repeatability and intermediate precision testing across analysts, days, or equipment.

ICH Q2(R2)

↓

7Execute linearity, range, and LOD/LOQ studies

Linearity and range confirmed across the method's intended working range, with detection and quantitation limits established for impurity methods.

ICH Q2(R2)

↓

Do results meet all pre-defined acceptance criteria?

YES → Proceed to data analysis and report NO → Investigate and revise

Phase 3

Data Analysis and Acceptance Evaluation

8Perform statistical analysis of validation data

Validation data statistically analyzed, calculating %RSD, correlation coefficients, recovery percentages, and other required statistical measures.

ICH Q2(R2)

↓

9Compare against pre-defined acceptance criteria

Calculated results compared directly against the acceptance criteria fixed in the approved protocol, not adjusted retrospectively to fit the results obtained.

ICH Q2(R2)

↓

10Document any atypical result and its resolution

Any result falling outside acceptance criteria investigated and documented, following a process comparable in rigor to an OOS investigation.

21 CFR 211.192

Phase 4

Transfer, Verification and Lifecycle Maintenance

11Compile and approve the validation summary report

Complete validation summary report compiled and formally approved, establishing the method as validated for its intended use.

ICH Q2(R2)

↓

12Perform method transfer or verification

Method transferred to a receiving laboratory, or verified for compendial methods, confirming the receiving site can execute it with equivalent performance.

USP <1225>

↓

13Maintain through system suitability and review

Ongoing method performance confirmed through system suitability testing at each use, with periodic review and revalidation triggered by significant changes.

ICH Q2(R2)

Validation Requirements by Method Type

Identification Methods

Primarily require demonstrated specificity, confirming the method can distinguish the target analyte from closely related compounds.

ICH Q2(R2)

Impurity Methods (Limit and Quantitative)

Require specificity plus detection or quantitation limits; quantitative impurity methods additionally require accuracy, precision, and linearity.

ICH Q2(R2)

Assay Methods

Require the fullest characteristic set, including specificity, accuracy, precision, and linearity, given their direct role in quantifying active content.

ICH Q2(R2)

Atypical Validation Result Response Steps

Step 1 - Document the result exactly as obtained Record the atypical result precisely as generated before any further investigation or reprocessing begins.

Step 2 - Perform an initial laboratory assessment Review for an obvious, assignable laboratory error, such as a documented instrument malfunction or sample preparation mistake.

Step 3 - Determine whether the method or the protocol needs revision Assess whether the atypical result reflects a genuine method limitation, requiring protocol or method development revision.

Step 4 - Re-execute the specific characteristic if justified Where a documented, assignable cause supports it, re-execute the specific validation characteristic rather than the entire protocol.

Step 5 - Document the full investigation and outcome Maintain a complete record connecting the atypical result, investigation, and either resolution or method revision decision.

Statistical Acceptance Requirements

Precision expressed as %RSD Repeatability and intermediate precision expressed as percent relative standard deviation, compared against a pre-defined acceptance threshold.

Linearity expressed via correlation coefficient Linearity demonstrated using a correlation coefficient or equivalent statistical measure, evaluated against the range the method will be used for.

Accuracy expressed as percent recovery Accuracy demonstrated through percent recovery studies at multiple concentration levels spanning the intended range.

Criteria fixed before data generation All acceptance criteria fixed in the approved protocol prior to data generation, preventing criteria from being adjusted to fit obtained results.

Method Lifecycle Elements

Analytical Target Profile Prospective definition of the method's required performance, anchoring both development decisions and validation acceptance criteria.

Robustness Assessment Evaluation of the method's reliability under small, deliberate variations in operating conditions, supporting confidence in routine use.

System Suitability Testing Routine checks performed at each method use, confirming the analytical system is performing adequately before sample results are accepted.

Method Transfer Protocol Formal, documented process confirming a receiving laboratory can execute the method with equivalent performance to the originating laboratory.

Revalidation Triggers Defined events, such as a significant formulation or synthetic route change, that trigger a formal revalidation assessment.

Stability-Indicating Capability For stability-related methods, demonstrated ability to detect and distinguish relevant degradation products from the intact analyte.

Compendial Method Verification For methods taken directly from a pharmacopeial monograph, verification confirming the method performs as expected under actual laboratory conditions.

Analytical Instrument Qualification Instruments used in validation qualified and maintained under a calibration programme, supporting the reliability of the underlying data.

Never do this

Adjust acceptance criteria after validation data has already been generated and reviewed. Skip specificity testing against known degradants for a stability-indicating method. Transfer a method to a new laboratory without a documented transfer protocol and acceptance criteria. Treat system suitability failure as a reason to simply re-inject rather than investigate.

Validation vs verification vs transfer

Validation establishes a new method is suitable for its intended purpose from first principles. Verification confirms an already-validated compendial method performs adequately under the specific laboratory's conditions. Transfer confirms a validated method performs equivalently when moved to a new, receiving laboratory.

ICH Q2(R2) vs USP <1225>

ICH Q2(R2) provides the internationally harmonized framework for which validation characteristics apply to which method category. USP <1225> provides closely aligned, complementary guidance with particular emphasis on verification of compendial methods within the U.S. pharmacopeial system.

Key regulations

ICH Q2(R2) - validation characteristics by analytical procedure type. USP <1225> - validation and verification of compendial procedures. ICH Q14 - analytical procedure development and Analytical Target Profile framework. 21 CFR 211.165(e) - test method validation requirement.